ANAB
AnaptysBio Inc
45.70$
-4.7%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 78.0% | 97.4% | 95.0% | 93.6% | 76.7% | 85.3% | 86.8% | 95.2% | 86.1% | 73.3% | 89.9% | 89.3% | 96.1% | |
| 71.8% | 88.5% | 91.8% | 82.4% | 24.7% | 22.3% | 39.3% | 60.1% | 77.1% | 11.7% | 8.0% | 25.4% | 65.4% | |
| 71.8% | 88.5% | 91.8% | 82.4% | 75.4% | 83.9% | 86.0% | 94.5% | 85.2% | 72.3% | 86.4% | 79.6% | 85.5% | |
| – | 5.8% | 2.2% | 8.6% | 0.5% | 0.0% | – | 0.0% | 0.1% | 0.2% | 1.5% | 8.4% | 9.3% | |
| – | – | – | 0.0% | 0.0% | – | – | – | 0.0% | 0.0% | 0.0% | – | – | |
| – | 2.3% | 1.0% | 0.8% | 0.2% | 0.3% | 0.7% | 0.4% | 0.4% | 0.3% | – | – | – | |
| – | – | – | – | 0.0% | – | – | – | – | – | – | – | – | |
| – | – | – | – | 0.0% | – | – | – | – | – | – | – | – | |
| 96.3% | 76.1% | 24.8% | 36.8% | 6.6% | 4.4% | 6.9% | 4.8% | 44.6% | 57.1% | 80.5% | 85.4% | 89.8% | |
| 80.8% | 46.6% | 13.1% | 9.2% | 4.3% | 4.3% | 6.8% | 4.8% | 2.5% | 4.3% | 8.3% | 9.4% | 10.6% | |
| 23.8% | 0.5% | 0.0% | 0.0% | 2.1% | 1.5% | 0.5% | 0.1% | 0.2% | 0.3% | 0.4% | 0.4% | 0.6% | |
| 5.0% | 1.7% | 2.7% | 3.7% | 0.7% | 1.1% | 3.7% | 1.0% | 0.3% | 0.5% | 1.0% | 0.8% | 1.1% | |
| – | 19.1% | 8.7% | 22.2% | 2.3% | 0.1% | – | – | – | – | – | – | – | |
| 3.7% | 23.9% | 75.2% | 63.2% | 93.4% | 95.6% | 93.1% | 95.2% | 55.4% | 42.9% | 19.5% | 14.6% | 10.2% | |
| -1,246.6% | -180.6% | -90.0% | -88.3% | -25.8% | -28.8% | -56.1% | -63.4% | -50.0% | -73.8% | -135.7% | -156.9% | -212.0% | |
| 28.4% | 9.9% | 4.5% | 4.2% | 6.0% | 4.8% | 6.2% | 6.6% | 4.3% | 4.6% | 6.0% | 5.9% | 8.6% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.